These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Drug therapy of hypertriglyceridemias (author's transl)].
    Author: Gries FA.
    Journal: MMW Munch Med Wochenschr; 1980 Mar 28; 122(13):471-3. PubMed ID: 6769019.
    Abstract:
    As a rule, the causal therapy of hypertriglyceridemia is possible only for its secondary forms. Indications for therapy are: a critical rise in triglyceride levels leading to symptoms of acute abdomen, disturbances of the lesser circulation, insulin-resistance or a reduction in the patient's working capacity. Triglyceride levels of 200 mg/dl are considered the threshold value for long-term therapy. In most cases, the desired can be obtained with dietary measures. Drug therapy mainly consists of nicotinic acid and its derivates, clofibrinic acid and its derivates as well as clofibrate successors.
    [Abstract] [Full Text] [Related] [New Search]